May 12, 2022
Ryosuke Mori, President
LIFENET INSURANCE COMPANY(Securities Code: 7157, TSE Growth)Amendment to Financial Resultsfor Fiscal 2020 Ended March 31, 2021
TOKYO, May 12, 2022 - LIFENET INSURANCE COMPANY (TSE Growth 7157, President
Ryosuke Mori, URL: https://ir.lifenet-seimei.co.jp/en/) hereby announces that amendment has
been made to Financial Results for Fiscal 2020 Ended March 31, 2021 released on May 13,2021. The amendment is as below.
Financial Results for Fiscal 2020 Ended March 31, 2021 (Underlines denote amendment)
Page 11(3) Statements of Changes in Net Assets
Capital surplus
Total capital surplus(Before amendment)(In millions of yen)
Year ended March 31
2020
Capital surplus

2021
12,136

12,220(After amendment)(In millions of yen)
Year ended March 31
2020
Capital surplus

2021
12,136

Statements of Changes in Net Assets after amendment is as shown on the page 2.

1

12,200(3) Statements of Changes in Net Assets(In millions of yen)
Year ended March 31
2020
2021
Shareholders' equity:
Capital stock
Balance at the beginning of the year ·························
Changes of items during the period
Issuance of new shares ···································
Issuance of new shares-restricted stock ··············
Issuance of new shares-exercise of subscription rights to shares
Total changes of items during the period ·············
Balance at the end of the period ·······························
Capital surplus
Legal capital surplus
Legal capital surplus ·······································
Changes of items during the period
Issuance of new shares ·······························
Issuance of new shares-restricted stock ··········
Issuance of new shares-exercise of subscription rights to shares ·Total changes of items during the period ·········
Legal capital surplus ··············································
Total capital surplus
Capital surplus ···············································
Changes of items during the period
Issuance of new shares ·······························
Issuance of new shares-restricted stock ··········
Issuance of new shares-exercise of subscription rights to shares ·Total changes of items during the period ·········
Capital surplus ···············································
Retained earnings
Other retained earnings
Retained earnings brought forward
Retained earnings brought forward·················
Total changes of items during the period
Net income (loss) ···································
Total changes of items during the period ·····
Retained earnings brought forward·················
Total retained earnings
Retained earnings ········································
Changes of items during the period
Net income (loss) ·····································
Total changes of items during the period ·······
Retained earnings ·······································
Treasury shares
Balance at the beginning of the year ·························
Changes of items during the period
Purchase of treasury shares ·····························
Total changes of items during the period ·············
Balance at the end of the period ·······························
212,136

12,200－2042
63
12,2004,502
2084,531
16,731

12,136

12,200－2042
63
12,2004,502
2084,531
16,731

12,136

12,200－2042
63
12,2004,502
2084,531
16,731(13,101)(15,502)(2,400)(2,400)(15,502)(3,114)(3,114)(18,616)(13,101)(15,502)(2,400)(2,400)(15,502)(3,114)(3,114)(18,616)

－－－－
－

(0)
(0)
(0)